Morphine extended release - Egalet

Drug Profile

Morphine extended release - Egalet

Alternative Names: AD ER morphine; ARYMO; EG-P113; EG-PO66 Morphine; Egalet Morphine; Egalet-001; Morphine sulfate - Egalet; Opioid 1

Latest Information Update: 12 Jun 2017

Price : $50

At a glance

  • Originator Egalet
  • Class Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain

Most Recent Events

  • 11 Jun 2017 The label for morphine extended release contains boxed warning
  • 05 Jun 2017 Egalet has patent protection for Guardian Technology in USA
  • 30 Mar 2017 Launched for Pain in USA - First global launch (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top